Liquid Dosage
Protein-based therapeutics are increasingly being developed as new chemical entities in the pharmaceutical and life science industries. Unlike small molecules, which are typically synthesized using chemical processes, most proteins need to be processed in living systems, mostly by recombinant DNA technology. The proteins can then be produced in their functional form (quaternary structure), rather than by microbial biosynthesis (bacteria/yeast), substantially reducing the downstream stages of the process.
As the demand for large-volume products increases, so does the requirement for higher capacity reactors (up to 20,000 L) to realize economies of scale. GEA has responded to the changing needs of biopharmaceutical manufacturers and developed improved technology solutions to optimize both upstream and, with increasing titers, downstream processing, in terms of time and cost efficiency.
Based on its history of innovation and process development, GEA has a thorough working knowledge of therapeutic protein production and has used this competence to design better media and feeding strategies, optimize the fermentation stage and enhance physicochemical conditions during the manufacturing process.
A leading international supplier of integrated process systems, our extensive portfolio of products, technologies and services includes standard and customized fermenters, separators and entire production lines, as well as plant for the production, storage and distribution of clean utilities. Systems for the preparation of media, fluid management, cell cultivation and purification are also part of our global scope of supply.
As a competent manufacturer of complete plant for the life science industries, GEA is a full-service provider of solutions that meet your exact requirements and specifications. From planning, development and installation to qualification and maintenance, our experienced engineers will collaborate with your project team to supply innovative and efficient process solutions for your applications.
Mostrar 4 de 29
Los cabezales de compresión de GEA son el elemento central del homogeneizador puesto que bombean el producto a alta presión hasta que fluye por el interior de la válvula de homogeneización y de esta forma activan el proceso de homogeneización.
El separador clarificador centrífugo se utiliza para separar sólidos de líquidos. El separador incorpora discos cónicos apilados para crear una gran zona de aclarado dentro de un tambor que tiene un volumen relativamente pequeño.
La combinación del control de los procesos mediante analizadores en línea con principios de ingeniería de procesos sólidos y técnicas avanzadas de modelización de procesos permitirá controlar los procesos de forma activa para compensar las variaciones de entrada.
The pump models in the GEA Varipump line are conceived for extreme application demands and are individually optimized for your task.
Cada gota y cada kilovatio/hora cuentan cuando se trata del desarrollo de centrífugas. GEA lleva más de 130 años creando centrífugas, algo que no se cuestiona todos los días. Jürgen Mackel, vicepresidente de la línea de productos...
Mediante inversiones en energías renovables, GEA reduce sus emisiones de CO2 en todo el mundo.
Cuando se trata de mejorar la salud del planeta, GEA asume un rol de liderazgo. Como uno de nuestros objetivos estratégicos centrados en la sostenibilidad, estamos forjando un camino para ayudar a nuestros clientes de una miríada...